MedPath

Infrascan, Inc.

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:1

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)โ€ข Click on a phase to view related trials

Not Applicable
1 (100.0%)

SAFETY: Stabilization Points to Third Hospital Line Assessment oF the Impact of the usE of Infrascanner Model 2500 to Provide Decision Support for Diagnosis/Screening of Traumatic Brain InjurY in Ukraine

Recruiting
Conditions
Traumatic Brain Hemorrhage
First Posted Date
2025-06-11
Last Posted Date
2025-06-11
Lead Sponsor
InfraScan, Inc.
Target Recruit Count
600
Registration Number
NCT07014748
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Alabama in Birmingham, Birmingham, Alabama, United States

๐Ÿ‡บ๐Ÿ‡ฆ

Dnipropetrovsk Regional Clinical Hospital named after I.I. Mechnikov of Dnipropetrovsk Regional Council, Dnipro, Ukraine

๐Ÿ‡บ๐Ÿ‡ฆ

Ukrainian Military, Kyiv, Ukraine

and more 1 locations

A Multi-Center Study of Near-Infrared Spectroscopy (NIRS) for Hematoma Detection

Not Applicable
Completed
Conditions
TBI (Traumatic Brain Injury)
First Posted Date
2007-12-18
Last Posted Date
2018-11-07
Lead Sponsor
InfraScan, Inc.
Target Recruit Count
431
Registration Number
NCT00576147
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Johns Hopkins University, Baltimore, Maryland, United States

๐Ÿ‡บ๐Ÿ‡ธ

University of Cincinnati, Cincinnati, Ohio, United States

๐Ÿ‡บ๐Ÿ‡ธ

The Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

and more 1 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

ยฉ 2025 MedPath, Inc. All rights reserved.